An interventional study of Double-Layer Vaginal Vault Closure with Self-Locking Suture and Double-Layer Vaginal Vault Closure with Polyglactin 910 in Gynecologic Cancers, Vaginal Cuff Dehiscence and Postoperative Complications, sponsored by Azienda Ospedaliero-Universitaria di Parma. Recruiting at 5 sites in Italy. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-17.
Sponsored by Azienda Ospedaliero-Universitaria di Parma · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Postoperative Complications with a site in Italy — 16 open to participants now, 18 under way, 1 of them phase 3. Postoperative Complications · Italy.
Among the 59 studies in Postoperative Complications with a site in Italy, this one is the 6th largest by planned enrollment of the 35 interventional ones that give a count, is one of 4 that started in 2025, is one of 30 with no phase, reaches primary completion later than 8 of the 17 other live ones, and was the 51st registered.
1,343 studies on the registry are indexed under Postoperative Complications; 314 are open to participants now.
Browse Postoperative Complications studies →16 of the 59 studies in Postoperative Complications with a site in Italy are open now. Recruiting first, the newest first:
IRCCS San Raffaele · Sites in Italy
Ages 18+
Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva · Sites in Italy
Ages 18+
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria · Sites in Italy
Ages 18+
Zealand Pharma · Sites in Italy, United States, Austria and 11 more countries
Ages 18–90
Azienda Ospedaliero-Universitaria di Parma · Sites in Italy
Ages 18+
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 200 Postoperative Complications studies recruiting now, 126 (63%) set no upper age limit and 31 (16%) stop at 75 or younger; 24 take children under 18; 25 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 3 · Phase 4 1
First in 1998; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 310 is above the median of 113 across 773 interventional studies indexed under Postoperative Complications.
Median enrollment 150 across the 35 interventional studies, 500 across the 23 observational. Of the 31 that completed or were terminated, 2 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 59 have an industry lead sponsor. The 10 most frequent:
Azienda Ospedaliero-Universitaria di Parma is the lead sponsor of 44 studies on the registry; 13 are open to participants now.
Azienda Ospedaliero-Universitaria di Parma has 3 studies filed under Postoperative Complications — fewer than ten, so there is no comparison to draw.
8 of the studies in Postoperative Complications with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06069297IRCCS San RaffaelePrehabilitation in Pancreatic Surgery | 2026-12-16 |
| NCT07313839Azienda Ospedaliero-Universitaria di ParmaComparison of Self-Locking Versus Traditional Sutures in Double-Layer Laparoscopic Vaginal Vault Closure After Hysterectomy (BI-SURE Trial) | 2027-01 |
| NCT07949526IRCCS San RaffaeleCompressive Dressing and Pharyngocutaneous Fistula After Primary Total Laryngectomy | 2027-01-05 |
| NCT07729891Azienda Ospedaliero-Universitaria di ParmaReal-time Evaluation and Continuous Observation of Vital Signs for Enhanced Recovery: a Study for the Early Identification of Complications in the Surgical Ward Following Surgery in Patients Not Eligible for Intensive Care Admission. | 2027-02 |
| NCT06904872Napo Therapeutics, S.p.A.Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC) | 2027-03 |
Add all 8 to your calendar (.ics) → With an account.
Among the 59 studies in Postoperative Complications with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Vaginal vault closure after laparoscopic or robotic hysterectomy may be associated with postoperative complications such as vaginal cuff dehiscence, infection, and bleeding. The optimal suture material and technique for laparoscopic colporrhaphy, particularly in patients undergoing surgery for gynecologic malignancies, remain controversial.
The BI-SURE trial is a multicenter, randomized controlled study designed to compare double-layer self-locking sutures versus double-layer traditional Polyglactin 910 sutures for laparoscopic vaginal vault closure after hysterectomy. The study aims to evaluate postoperative effectiveness and safety within three months after surgery.
Laparoscopic and robotic hysterectomy represent standard surgical approaches for the treatment of gynecologic malignancies but are associated with a higher risk of vaginal vault complications compared with open or vaginal surgery. Although uncommon, postoperative complications such as vaginal cuff dehiscence, infection, and bleeding may lead to significant morbidity and require additional medical or surgical interventions.
Vaginal vault closure can be performed using different suturing techniques and materials. Traditional braided sutures, such as Polyglactin 910, are widely used in clinical practice, while self-locking (barbed) sutures have been introduced to facilitate laparoscopic suturing by maintaining tissue approximation without the need for knots. Evidence comparing these sutures is limited, particularly for double-layer closure techniques and in patients treated for gynecologic malignancies.
The BI-SURE trial is a multicenter, pragmatic, randomized controlled trial designed to compare double-layer self-locking sutures versus double-layer traditional Polyglactin 910 sutures for laparoscopic vaginal vault closure following hysterectomy for malignant gynecologic disease. Eligible patients will be randomized in a 1:1 ratio. Postoperative outcomes will be assessed up to three months after surgery, including vaginal cuff-related complications and postoperative pain.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants randomized to this arm will undergo laparoscopic vaginal vault closure after hysterectomy using a double-layer continuous suturing technique performed with a self-locking (barbed) suture, according to current clinical practice.
Procedure: Double-Layer Vaginal Vault Closure with Self-Locking Suture
Participants randomized to this arm will undergo laparoscopic vaginal vault closure after hysterectomy using a double-layer continuous suturing technique performed with traditional braided Polyglactin 910 suture, according to current clinical practice.
Procedure: Double-Layer Vaginal Vault Closure with Polyglactin 910
Laparoscopic vaginal vault closure performed using a double-layer continuous suturing technique with a self-locking (barbed) suture following hysterectomy.
Laparoscopic vaginal vault closure performed using a double-layer continuous suturing technique with traditional braided Polyglactin 910 suture following hysterectomy.
Vaginal cuff dehiscence rate
Proportion of participants experiencing vaginal cuff dehiscence requiring surgical reintervention after laparoscopic hysterectomy.
Time frame: Within 3 months after surgery
Vaginal cuff infection rate
Proportion of participants developing vaginal cuff infection, defined as abnormal vaginal discharge with or without fever, leukocytosis, and/or local tenderness, requiring antibiotic therapy.
Time frame: Within 3 months after surgery
Postoperative bleeding rate
Proportion of participants experiencing postoperative vaginal cuff bleeding requiring hemostatic treatment.
Time frame: Within 3 months after surgery
Postoperative pain intensity
Postoperative pain assessed using the Visual Analogue Scale (VAS).
Time frame: At 1 month and 3 months after surgery
Early postoperative composite complication rate
Proportion of participants experiencing vaginal cuff dehiscence, infection, or bleeding before the initiation of adjuvant therapy.
Time frame: Within 1 month after surgery
Plan to share: No — Individual participant data (IPD) will not be shared because the study is conducted within a hospital-based academic setting and no data repository has been designated for public data release. Data will be stored securely at the sponsor institution and will be accessible only to authorized study personnel in compliance with applicable privacy regulations.
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Jan 2027, 15 months after the start.
Of 395 non-industry interventional studies with no phase under Postoperative Complications, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 44. This study's planned 15 months is below that.
Counting every sponsor, half of 399 studies reached it within 20 months; a quarter within 8 and three quarters within 44.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Azienda Ospedaliero-Universitaria di Parma